IRF3 and head and neck squamous cell carcinoma: The close relationship between cGAS-STING-IRF3 pathway and immunotherapy was also well documented 19, 31, 34, suggesting that MYCi975 could be also used to enhance the sensitivity of HNSCC to immunotherapy in the future.